Literature DB >> 11314533

The expression of E-cadherin-catenin complex in adenoid cystic carcinoma of salivary glands.

Z Y Zhang1, Y Q Wu, W G Zhang, Z Tian, J Cao.   

Abstract

OBJECTIVE: The aim of this study was to investigate the expression of the E-cadherin-catenin (E-cad-cat) complex in human salivary adenoid cystic carcinoma (ACC) and determine the effects of E-cad-cat expression on tumor differentiation, metastasis, and invasion, as well as its clinical significance.
METHODS: The expression of adhesion molecules, which included E-cadherin, alpha-catenin, and beta-catenin, on 10 cases of normal salivary glands, and 50 cases of human salivary ACC were investigated by immunohistochemistry.
RESULTS: Strong and stable expression of E-cad-cat complex showed in normal salivary glands tissues. However, weaker expression and even complete absence, of the positive signals were shown on all ACC cases. Coexpression of E-cad-cat were detected in 29 (58%) of the 50 ACC specimens. Positive staining of E-cad-cat complex were detected in 7 (39%) of the 18 ACC primary sites that had aggressive phenotype of nerve and vasculature.
CONCLUSION: Strong positive signals of E-cad-cat complex are shown in normal salivary glands, and the down-regulated expression were observed in ACC cases. The expression of E-cad-cat complex is associated with a more aggressive phenotype on nerve and vasculature. No association with various histopathologic subtypes was found. However, absent or low E-cad expression was observed more frequently in solid carcinomas than in cribriform or tubular carcinomas. Down-regulation of E-cad-cat complex may be associated with canceration of normal salivary glands. The expression levels of E-cad-cat were positively correlated to the differentiation of ACC tumor cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11314533

Source DB:  PubMed          Journal:  Chin J Dent Res        ISSN: 1462-6446


  8 in total

Review 1.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

2.  Clinical implication of CD166 expression in salivary gland tumor.

Authors:  Azadeh Andisheh-Tadbir; Mohammad Javad Ashraf; Bijan Khademi; Shahab Ahmadi
Journal:  Tumour Biol       Date:  2014-12-04

3.  Evaluation of immunohistochemical expression of E-cadherin in pleomorphic adenoma and adenoid cystic carcinoma.

Authors:  Bhavani Nagendra Sangala; Vandana Raghunath; Pratibha Kavle; Anish Gupta; Swati Shrikant Gotmare; Venkata Subhash Andey
Journal:  J Oral Maxillofac Pathol       Date:  2022-03-31

Review 4.  Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.

Authors:  Jacqueline M Benjamin; W James Nelson
Journal:  Semin Cancer Biol       Date:  2007-09-04       Impact factor: 15.707

5.  [Advances in the molecular mechanisms of perineural invasion in salivary adenoid cystic carcinoma].

Authors:  Mei Zhang; Xin-Hua Liang; Ya-Ling Tang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-04-01

6.  CDH4 suppresses the progression of salivary adenoid cystic carcinoma via E-cadherin co-expression.

Authors:  Jian Xie; Yan Feng; Ting Lin; Xiao-Yu Huang; Rui-Huan Gan; Yong Zhao; Bo-Hua Su; Lin-Can Ding; Lin She; Jiang Chen; Li-Song Lin; Xu Lin; Da-Li Zheng; You-Guang Lu
Journal:  Oncotarget       Date:  2016-12-13

7.  Different cDNA microarray patterns of gene expression reflecting changes during metastatic progression in adenoid cystic carcinoma.

Authors:  Dan Huang; Wantao Chen; Ronggen He; Fan Yu; Zhiyuan Zhang; Weiliu Qiu
Journal:  World J Surg Oncol       Date:  2003-12-19       Impact factor: 2.754

8.  Immunophenotypical alterations with impact on the epithelial-mesenchymal transition (EMT) process in salivary gland adenoid cystic carcinomas.

Authors:  Iulia Cristiana Belulescu; Claudiu Mărgăritescu; Cristiana Iulia Dumitrescu; Maria Cristina Munteanu; Otilia Clara Mărgăritescu
Journal:  Rom J Morphol Embryol       Date:  2020       Impact factor: 1.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.